Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8916)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2015 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Lim JH, Lee DH, Lee ST, Kim N, Park YS, Shin CM, Song IS. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i46/13124.htm |
| Number | Citing Articles |
| 1 |
Dan Wang, Qianqian Guo, Yuan Yuan, Yuehua Gong. The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer. BMC Microbiology 2019; 19(1) doi: 10.1186/s12866-019-1517-4
|
| 2 |
Hideki Mori, Hidekazu Suzuki. Update on quinolone-containing rescue therapies for <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2020; 26(15): 1733-1744 doi: 10.3748/wjg.v26.i15.1733
|
| 3 |
Muhammet Yener Akpinar, Evrim Kahramanoglu Aksoy, Ferdane Sapmaz, Zeynep Goktas, Metin Uzman, Yasar Nazligul. Comparison of moxifloxacin-based therapies and standard bismuth-based quadruple therapy for first-line treatment of Helicobacter pylori infection. Archives of Medical Science – Civilization Diseases 2018; 3(1): 81 doi: 10.5114/amscd.2018.78766
|
| 4 |
Sumaira Khadim, Iyad Naeem Muhammad, Tanveer Alam, Shahnaz Usman, Hina Rehman, Sajjad Haider. Predictors of Successful First-Line Helicobacter pylori Eradication with Fluoroquinolones in Pakistan: A Prospective Exploration of Demographic and Clinical Factors. Antibiotics 2024; 13(3): 211 doi: 10.3390/antibiotics13030211
|
| 5 |
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opinion on Pharmacotherapy 2022; 23(1): 63 doi: 10.1080/14656566.2021.1959914
|
| 6 |
Alicia C. Marin, Olga P. Nyssen, Adrian G. McNicholl, Javier P. Gisbert. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Drugs 2017; 77(7): 765 doi: 10.1007/s40265-017-0730-4
|
| 7 |
Brian White, Maria Winte, Joshua DeSipio, Sangita Phadtare. Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients. Microorganisms 2022; 10(2): 322 doi: 10.3390/microorganisms10020322
|
| 8 |
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016. Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
|
| 9 |
Andrzej Czyrski, Agnieszka Sokół, Edyta Szałek. HPLC method for determination of moxifloxacin in plasma and its application in pharmacokinetic analysis. Journal of Liquid Chromatography & Related Technologies 2017; 40(1): 8 doi: 10.1080/10826076.2017.1280680
|
| 10 |
Darsh Gautam, Poonam Talwan, Sahil Dhiman, Rahul Gill, Aparna Thakur, Simran Dhiman, Deexa Sharma, Akhil Kumar, Saksham Sharma. Amoxicillin-loaded Nanotechnological Carriers for the Effective
Treatment of Helicobacter pylori Infection. Micro and Nanosystems 2023; 15(4): 245 doi: 10.2174/0118764029259927231127094657
|
| 11 |
Muhammad Riaz, Christina Chan, Christine Andrews, Michael Herzlinger, Enju Liu, Silvana Bonilla. Factors associated with Helicobacter pylori antimicrobial resistance in a US pediatric cohort. Journal of Pediatric Gastroenterology and Nutrition 2025; 80(1): 87 doi: 10.1002/jpn3.12421
|
| 12 |
Abdulrhman Khaled Al Abdulqader, Turki Abdullah Alamri, Mahdi Abdullah Alhamad, Somaia Shehab El‐Deen, Abdallah Essa, Raed Abdullah Alfayez, Baqer Mohammed Albaqshi, Adnan Salah Almajed, Mohammed Yousef Alhassan, Ali Essa, Ahmed Abdullah Albadrani, Omar Alomair, Bashaeer Abdullh Al Jalal, Mohammed Yousef Almulhim, Abdullah Alotaibi, Ehab Darwish. First‐Line Levofloxacin‐Based Triple Therapy Versus Standard Bismuth‐Based Quadruple Therapy for Helicobacter pylori Eradication in Saudi Arabia: A Retrospective Single‐Center Study. Health Science Reports 2025; 8(2) doi: 10.1002/hsr2.70432
|
| 13 |
Yuehua Gong, Yuan Yuan. Resistance mechanisms ofHelicobacter pyloriand its dual target precise therapy. Critical Reviews in Microbiology 2018; 44(3): 371 doi: 10.1080/1040841X.2017.1418285
|
| 14 |
Jing Yu, Yiming Lv, Peng Yang, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang. Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03002-z
|
| 15 |
Emily C. Tucker, Matthew B. Roberts, David L. Gordon. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2017; 39: 229 doi: 10.1016/bs.seda.2017.07.005
|